Testing for drugs of abuse in children and adolescents

Pediatrics

Volumn 133, Issue 6, 2014, Pages

  Levy, Sharon ^c   Siqueira, Lorena M ^c   Ammerman, Seth D ^c   Gonzalez, Pamela K ^c   Ryan, Sheryl A ^c   Smith, Vincent C ^c   Faden, Vivian B ^a   Tau, Gregory ^b   Jarrett, Renee ^c   Baumberger, James ^c   Crumley, Katie ^c  

^a National Institute of Alcohol Abuse and Alcoholism   (United States)

^b American Academy of Child and Adolescent Psychiatry   (United States)

^c NONE

Author keywords

Drug testing; Drug testing results; Positive and negative drug testing results

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; BUTALBITAL; CANNABINOID; CANNABIS; CARBON MONOXIDE; CLONAZEPAM; COCAINE; CODEINE; COTININE; CREATININE; DIAMORPHINE; DIAZEPAM; ILLICIT DRUG; LYSERGIDE; METHADONE; METHAMPHETAMINE; MORPHINE; NALOXONE; NICOTINE; PHENCYCLIDINE; PHENOBARBITAL; SECOBARBITAL; TETRAHYDROCANNABINOL; TRIAZOLAM;

ADULTERATED SPECIMEN; ALCOHOL CONSUMPTION; ARTICLE; BEHAVIOR DISORDER; BLOOD EXAMINATION; BREATH ANALYSIS; CLINICAL PRACTICE; CONFIDENTIALITY; COST BENEFIT ANALYSIS; CREATININE URINE LEVEL; DIAGNOSTIC ERROR; DILUTION; DRUG ABUSE; DRUG EXCRETION; DRUG SCREENING; EMERGENCY CARE; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HAIR ANALYSIS; HEALTH PROGRAM; HOME DIAGNOSTIC TEST; HOME DRUG TESTING; HUMAN; LABORATORY DIAGNOSIS; LAW; MECONIUM; MEDICAL CLEARANCE; MEDICOLEGAL ASPECT; MENTAL DISEASE; PEDIATRICIAN; POINT OF CARE TESTING; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; SALIVA ANALYSIS; SCHOOL; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; SUBSTITUTED SPECIMEN; SWEAT TEST; SYMPTOMATOLOGY; URINALYSIS;

ADOLESCENT; ALCOHOLISM; CHILD; DRUG EVALUATION, PRECLINICAL; EMERGENCY SERVICE, HOSPITAL; ETHANOL; HUMANS; INFANT, NEWBORN; MARIJUANA ABUSE; METABOLIC CLEARANCE RATE; PREDICTIVE VALUE OF TESTS; SPECIMEN HANDLING; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84901852187     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2014-0865     Document Type: Article

References (39)

1. The National Center on Addiction and Substance Abuse (CASA) at Columbia University. Adolescent Substance Use: America's #1 Public Health Problem. New York, NY: The National Center on Addiction and Substance Abuse (CASA) at Columbia University; 2011
2. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future National Survey Results on Drug Use, 1975-2011. Volume II. College Students and Adults Ages 19-50. Ann Arbor, MI: Institute for Social Research, University of Michigan; 2012
3. Hingson RW, Heeren T, Winter MR. Age at drinking onset and alcohol dependence: age at onset, duration, and severity. Arch Pediatr Adolesc Med. 2006;160(7):739-746
4. Substance Abuse and Mental Health Services Administration. Results From the 2009 National Survey on Drug Use and Health. Vol. I: Summary of National Findings [Publication No. SMA 10-4856]. Rockville, MD: Department of Health and Human Services, Office of Applied Studies; 2010
5. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication [published correction appears in Arch Gen Psychiatry. 2005;62(7):768]. Arch Gen Psychiatry. 2005;62(6):593-602 (Pubitemid 40973434)
6. Levy S, Harris SK, Sherritt L, Angulo M, Knight JR. Drug testing of adolescents in ambulatory medicine: physician practices and knowledge. Arch Pediatr Adolesc Med. 2006;160(2):146-150 (Pubitemid 43213858)
7. US Department of Transportation, Office of Drug and Alcohol Policy and Compliance. Urine Specimen Collection Guidelines. Available at: http://www.dot.gov/odapc/urine-specimen-collection-guidelines. Accessed July 12, 2013
8. Irwin CE Jr. To test or not to test: screening for substance use in adolescents. J Adolesc Health . 2006;38(4):329-331
9. Benowitz NL. Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol Rev. 1996;18(2):188-204 (Pubitemid 27082089)
10. Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol. 2009; 169(2):236-248
11. Bosker WM, Huestis MA. Oral fluid testing for drugs of abuse. Clin Chem. 2009;55(11):1910-1931
12. Drummer OH. Drug testing in oral fluid. Clin Biochem Rev. 2006;27(3):147-159
13. Kidwell DA, Smith FP. Minimal standards for the performance and interpretation of toxicology test in legal proceedings. J Forensic Sci. 2000;45(1):237-239
14. Chawarski MC, Fiellin DA, O'Connor PG, Bernard M, Schottenfeld RS. Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence. J Subst Abuse Treat. 2007;33(4):411-415 (Pubitemid 350030396)
15. Barnes AJ, De Martinis BS, Gorelick DA, Goodwin RS, Kolbrich EA, Huestis MA. Disposition of MDMA and metabolites in human sweat following controlled MDMA administration. Clin Chem. 2009;55(3):454-462
16. Huestis MA, Scheidweiler KB, Saito T, et al. Excretion of Delta9-tetrahydrocannabinol in sweat. Forensic Sci Int. 2008;174(2-3):173-177
17. Wennig R. Potential problems with the interpretation of hair analysis results. Forensic Sci Int. 2000;107(1-3):5-12 (Pubitemid 30019278)
18. Ropero-Miller JD, Huestis MA, Stout PR. Cocaine analytes in human hair: evaluation of concentration ratios in different cocaine sources, drug-user populations and surface-contaminated specimens. J Anal Toxicol. 2012;36(6):390-398
19. Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367(2):146-155
20. Petry NM, Tedford J, Austin M, Nich C, Carroll KM, Rounsaville BJ. Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom? Addiction. 2004;99(3):349-360 (Pubitemid 38333827)
21. Petry NM. A comprehensive guide to the application of contingency management procedures in clinical settings. Drug Alcohol Depend. 2000;58(1-2):9-25
22. Kamon J, Budney A, Stanger C. A contingency management intervention for adolescent marijuana abuse and conduct problems. J Am Acad Child Adolesc Psychiatry. 2005;44(6):513-521 (Pubitemid 40720950)
23. Carroll KM, Rounsaville BJ. A perfect platform: combining contingency management with medications for drug abuse. Am J Drug Alcohol Abuse. 2007;33(3):343-365 (Pubitemid 47037172)
24. Henggeler SW, Halliday-Boykins CA, Cunningham PB, Randall J, Shapiro SB, Chapman JE. Juvenile drug court: enhancing outcomes by integrating evidence-based treatments. J Consult Clin Psychol. 2006;74(1):42-54
25. Halliday-Boykins CA, Schaeffer CM, Henggeler SW, et al. Predicting nonresponse to juvenile drug court interventions. J Subst Abuse Treat. 2010;39(4):318-328
26. Levy S, Knight JR, Moore T, Weinstein Z, Sherritt L, Weiss RD. Acceptability of drug testing in an outpatient substance abuse program for adolescents. J Adolesc Health. 2011;48(3):229-233
27. Schwartz RH, Clark HW, Meek PS. Laboratory tests for rapid screening of drugs of abuse in the workplace: a review. J Addict Dis. 1993;12(2):43-56 (Pubitemid 23111790)
28. Hammett-Stabler CA, Pesce AJ, Cannon DJ. Urine drug screening in the medical setting. Clin Chim Acta. 2002;315(1-2):125-135 (Pubitemid 33145253)
29. Mears CJ, Knight JR; Council on School Health, American Academy of Pediatrics; Committee on Substance Abuse, American Academy of Pediatrics. The role of schools in combating illicit substance abuse. Pediatrics. 2007;120(6):1379-1384
30. Levy S, Van Hook S, Knight J. A review of Internet-based home drug-testing products for parents. Pediatrics. 2004;113(4):720-726 (Pubitemid 38437374)
31. American Academy of Pediatrics Committee on Substance Abuse. Testing for drugs of abuse in children and adolescents. Pediatrics. 1996;98(2 pt 1):305-307
32. Smith ML, Barnes AJ, Huestis MA. Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections. J Anal Toxicol. 2009;33(4):185-189
33. Veronia School Dist. 47J v Acton, 115 S Ct 2386 (1995)
34. Board of Education v Earls, 536 US 822 (2002)
35. Zacher JL, Givone DM. False-positive urine opiate screening associated with fluoroquinolone use. Ann Pharmacother. 2004;38(9):1525-1528 (Pubitemid 39100210)
36. Baden LR, Horowitz G, Jacoby H, Eliopoulos GM. Quinolones and false-positive urine screening for opiates by immunoassay technology. JAMA. 2001;286(24):3115-3119 (Pubitemid 34016526)
37. Levy S, Harris SK, Sherritt L, Angulo M, Knight JR. Drug testing of adolescents in general medical clinics, in school and at home: physician attitudes and practices. J Adolesc Health. 2006;38(4):336-342
38. Weisleder P. The right of minors to confidentiality and informed consent. J Child Neurol. 2004;19(2):145-148 (Pubitemid 38425768)
39. Weisleder P. Inconsistency among American states on the age at which minors can consent to substance abuse treatment. J Am Acad Psychiatry Law. 2007;35(3):317-322 (Pubitemid 47572995)